Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)
INR 19.5
(-4.97%)
INR 19.5
(-4.97%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 236.26 Million INR | 272.5% |
| 2022 | 46.58 Million INR | 265.9% |
| 2021 | 12.73 Million INR | 355.2% |
| 2020 | 2.79 Million INR | 349.97% |
| 2019 | 621.59 Thousand INR | -90.95% |
| 2018 | 6.86 Million INR | -21.82% |
| 2017 | 8.78 Million INR | -12.05% |
| 2016 | 9.98 Million INR | 36.34% |
| 2015 | 7.32 Million INR | 186.49% |
| 2014 | -8.46 Million INR | 2.95% |
| 2013 | -8.72 Million INR | -467.58% |
| 2012 | -1.53 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 8.05 Million INR | -87.13% |
| 2023 Q3 | 90.32 Million INR | 89.42% |
| 2023 FY | 173.53 Million INR | 272.5% |
| 2023 Q1 | 5.11 Million INR | -87.13% |
| 2023 Q2 | 47.68 Million INR | 832.66% |
| 2023 Q4 | 39.16 Million INR | -56.64% |
| 2022 Q1 | 5.4 Million INR | -85.35% |
| 2022 FY | 46.58 Million INR | 265.9% |
| 2022 Q2 | 499 Thousand INR | -90.77% |
| 2022 Q4 | 39.72 Million INR | 4046.56% |
| 2022 Q3 | 958 Thousand INR | 91.98% |
| 2021 Q2 | -23.09 Million INR | -1361.65% |
| 2021 Q4 | 36.9 Million INR | 614966.67% |
| 2021 Q3 | 6000.00 INR | 100.03% |
| 2021 Q1 | -1.58 Million INR | -141.75% |
| 2021 FY | 12.73 Million INR | 355.2% |
| 2020 Q4 | 3.78 Million INR | 1366.67% |
| 2020 Q1 | -1.2 Million INR | 78.59% |
| 2020 FY | 2.79 Million INR | 349.97% |
| 2020 Q2 | -39 Thousand INR | 96.77% |
| 2020 Q3 | 258 Thousand INR | 761.54% |
| 2019 Q3 | 5.99 Million INR | 143.58% |
| 2019 FY | 621.59 Thousand INR | -90.95% |
| 2019 Q1 | 34 Thousand INR | -99.14% |
| 2019 Q4 | -5.63 Million INR | -193.98% |
| 2019 Q2 | -13.75 Million INR | -40547.06% |
| 2018 FY | 6.86 Million INR | -21.82% |
| 2018 Q4 | 3.96 Million INR | 859.08% |
| 2018 Q3 | 413 Thousand INR | -47.39% |
| 2018 Q2 | 785 Thousand INR | -54.04% |
| 2018 Q1 | 1.7 Million INR | 127.64% |
| 2017 Q1 | 1.02 Million INR | -81.74% |
| 2017 Q2 | 95 Thousand INR | -90.71% |
| 2017 Q3 | 13.77 Million INR | 14397.89% |
| 2017 Q4 | -6.18 Million INR | -144.87% |
| 2017 FY | 8.78 Million INR | -12.05% |
| 2016 Q4 | 5.6 Million INR | 274.65% |
| 2016 FY | 9.98 Million INR | 36.34% |
| 2016 Q3 | 1.49 Million INR | 142.94% |
| 2016 Q2 | -3.48 Million INR | -275.95% |
| 2016 Q1 | 1.97 Million INR | -27.77% |
| 2015 FY | 7.32 Million INR | 186.49% |
| 2015 Q4 | 2.74 Million INR | 546.25% |
| 2015 Q3 | -614 Thousand INR | -167.55% |
| 2015 Q2 | 909 Thousand INR | -37.48% |
| 2015 Q1 | 1.45 Million INR | 117.64% |
| 2014 Q1 | 413 Thousand INR | -94.53% |
| 2014 Q3 | -931 Thousand INR | -191.91% |
| 2014 FY | -8.46 Million INR | 2.95% |
| 2014 Q4 | -8.24 Million INR | -785.4% |
| 2014 Q2 | 1.01 Million INR | 145.28% |
| 2013 Q3 | -3.13 Million INR | 38.25% |
| 2013 Q2 | -5.07 Million INR | 8.41% |
| 2013 Q1 | -5.54 Million INR | 76.07% |
| 2013 FY | -8.72 Million INR | -467.58% |
| 2013 Q4 | 7.54 Million INR | 340.72% |
| 2012 Q3 | 454 Thousand INR | -58.0% |
| 2012 FY | -1.53 Million INR | 0.0% |
| 2012 Q2 | 1.08 Million INR | 117.65% |
| 2012 Q1 | -6.12 Million INR | -139.76% |
| 2012 Q4 | -23.16 Million INR | -5202.71% |
| 2011 Q2 | 3.98 Million INR | 0.0% |
| 2011 Q3 | -840 Thousand INR | -121.06% |
| 2011 Q4 | 15.4 Million INR | 1933.8% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| ANG Lifesciences India Limited | 12.8 Million INR | -1745.068% |
| Add-Shop E-Retail Limited | 77.57 Million INR | -204.574% |
| Bacil Pharma Limited | -1.89 Million INR | 12571.943% |
| BDH Industries Limited | 169.01 Million INR | -39.786% |
| Beryl Drugs Limited | 14.73 Million INR | -1503.727% |
| Cian Healthcare Limited | 53.96 Million INR | -337.772% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | -1337.548% |
| Concord Drugs Limited | 24.87 Million INR | -849.908% |
| Deccan Health Care Limited | 185.32 Million INR | -27.482% |
| DECIPHER LABS LIMITED | 53.74 Million INR | -339.637% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | -2528.042% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 72.334% |
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | -44326.664% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 64.687% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | -2865.123% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 52.815% |
| Panchsheel Organics Limited | 288.28 Million INR | 18.047% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 725.741% |
| Parnax Lab Limited | 166.84 Million INR | -41.606% |
| Makers Laboratories Limited | -34.91 Million INR | 776.772% |
| Medi-Caps Limited | -17.21 Million INR | 1472.812% |
| MedPlus Health Services Limited | 1.31 Billion INR | 82.098% |
| Phaarmasia Limited | - INR | -Infinity% |
| Parmax Pharma Limited | 3.75 Million INR | -6192.658% |
| Patidar Buildcon Limited | -1.83 Million INR | 12968.246% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | -266.462% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 58292.365% |
| Trident Lifeline Limited | 72.21 Million INR | -227.181% |
| Tyche Industries Limited | 111.22 Million INR | -112.421% |
| Vivanza Biosciences Limited | 14.83 Million INR | -1492.914% |
| PRAVEG LIMITED | 185.06 Million INR | -27.661% |
| Smruthi Organics Limited | - INR | -Infinity% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | -591.732% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | -9.543% |
| Sastasundar Ventures Limited | -229.64 Million INR | 202.88% |
| Transchem Limited | -17.43 Million INR | 1454.785% |
| Trinity League India Limited | 1.17 Million INR | -20041.603% |
| Vikram Thermo (India) Limited | 339.45 Million INR | 30.401% |
| Vista Pharmaceuticals Limited | -10.14 Million INR | 2428.383% |
| Sunil Healthcare Limited | -19.98 Million INR | 1282.428% |
| Syschem (India) Limited | 504.91 Million INR | 53.208% |
| Zenith Healthcare Limited | 196 Thousand INR | -120441.327% |
| Zenlabs Ethica Limited | 89.27 Million INR | -164.638% |
| Mercury Laboratories Limited | 62.14 Million INR | -280.159% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | -139.444% |
| Vasundhara Rasayans Limited | 61.27 Million INR | -285.569% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 247.595% |
| Roopa Industries Limited | 48.05 Million INR | -391.627% |
| PANJON LTD. | - INR | -Infinity% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 258.233% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 1418.642% |
| Anuh Pharma Limited | 682.19 Million INR | 65.368% |
| Crestchem Limited | 27.25 Million INR | -766.825% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 2109.877% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | -1279.626% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | 35.139% |
| Trimurthi Limited | -6.14 Million INR | 3945.995% |
| Norris Medicines Limited | 11.15 Million INR | -2017.571% |
| Veerhealth Care Limited | 34.19 Million INR | -590.983% |
| Lactose (India) Limited | 137.78 Million INR | -71.47% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 291.193% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | 45.912% |
| Gennex Laboratories Limited | 146.61 Million INR | -61.141% |
| Denis Chem Lab Limited | 142.87 Million INR | -65.36% |
| Colinz Laboratories Limited | 14.64 Million INR | -1513.474% |
| Godavari Drugs Limited | -67.67 Million INR | 449.132% |
| Zenotech Laboratories Limited | 242.37 Million INR | 2.523% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 58.731% |
| Bharat Parenterals Limited | 733.49 Million INR | 67.789% |
| Coral Laboratories Limited | 142.63 Million INR | -65.643% |
| Evoq Remedies Limited | 42.91 Million INR | -450.507% |
| Kerala Ayurveda Limited | 48.04 Million INR | -391.739% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | 9626.653% |
| Natural Capsules Limited | 112.4 Million INR | -110.197% |
| Auro Laboratories Limited | 95.77 Million INR | -146.683% |